why was tirzepatide banned FDA Ban on Compounded GLP-1 Drugs: What to Know The FDA is considering banning

Within h to 5 days of exposure to hypobaric hypoxia, some individuals are susceptible to acute altitude illness, including mild (AMS) and severe (HAPE and HACE) forms (Fig

However, baseline assessment and periodic monitoring may be appropriate for patients with known hepatic conditions or metabolic risk factors

These wonky conversions have even confused doctors

According to PharmaTrac data, India's anti-obesity drug market reached Rs 628 crore for the twelve months ending June 2025, a fivefold increase over five years, driven largely by the introduction of GLP-1 therapies

One of the most common side effects includes nausea or queasiness

These effects promote monocyte adhesion and foam cell formation, accelerating AS progression